Breaking News Instant updates and real-time market news.

EGLT

Egalet

$1.15

-0.04 (-3.36%)

08:52
12/07/17
12/07
08:52
12/07/17
08:52

Egalet cash runway through 2020 remains intact, says Cantor Fitzgerald

In a research note titled "You Win Some, You Lose Some; Cash Runway Through 2020 Remains Intact," Cantor Fitzgerald analyst Brandon Folkes says news of CVS (CVS) removing Sprix from its 2018 formulary is a negative for Egalet (EGLT). The development offsets the positive news announced last month that Apotex will not be launching an authorized generic of Sprix in March 2018, Folkes tells investors. He believes, however, that Egalet's cash runway through 2020 remains, even if Sprix revenues in 2018 are reduced by 50%. The analyst thinks Arymo ER is the primary driver of valuation for Egalet. He keeps an Overweight rating on the shares with a $7 price target.

EGLT Egalet
$1.15

-0.04 (-3.36%)

06/09/17
JMPS
06/09/17
NO CHANGE
JMPS
Egalet may benefit from increased scrutiny of opioids, says JMP Securities
After the FDA requested that Endo (ENDP) remove its Opana ER opioid from the market due to increased risk of abuse using injections, JMP Securities analyst Jason Butler says that Egalet's (EGLT) abuse deterrent opioid alternatives could be boosted by the FDA's increased scrutiny of opioids. The analyst reiterates a $15 price target and Outperform rating on the stock.
08/14/17
CANT
08/14/17
INITIATION
CANT
Overweight
Egalet coverage assumed with an Overweight at Cantor
Cantor analyst Brandon Folkes, assumed coverage of Egalet with a $7 price target and an Overweight rating. He says that the company is poised "to benefit from the need to reduce opioid abuse" while lowering patients' pain. The analyst says that a "strong launch" of the company's Arymo ER drug could spur many more investors to buy its shares.
09/12/17
CANT
09/12/17
NO CHANGE
Target $7
CANT
Overweight
Investors should consider owning Egalet, says Cantor
Cantor Fitzgerald analyst Brandon Folkes saying the company's five posters at Pain Week last week reinforced the sales potential of, and need for, abuse deterent products such as Arymo ER. With three approved products and a cash runway through 2020, investors should consider owning Egalet shares, Folkes tells investors in a research note. He reiterates an Overweight rating on the shares with a $7 price target.
11/09/17
GABE
11/09/17
DOWNGRADE
GABE
Hold
Egalet downgraded to Hold from Buy at Gabelli
Gabelli analyst Kevin Kedra downgraded Egalet to Hold citing challenges for Arymo, potential generic competition for Sprix, and lack of near-term catalysts.

TODAY'S FREE FLY STORIES

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
08/15/18
08/15
12:17
08/15/18
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
08/15/18
08/15
12:16
08/15/18
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$280.78

-3.02 (-1.06%)

12:11
08/15/18
08/15
12:11
08/15/18
12:11
Technical Analysis
Technical Take: SPDR S&P 500 ETF off lows at midday »

The SPDR S&P 500 ETF…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$280.78

-3.02 (-1.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VOD

Vodafone

$22.53

-0.635 (-2.74%)

12:10
08/15/18
08/15
12:10
08/15/18
12:10
Recommendations
Vodafone analyst commentary  »

Vodafone added as a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$335.00

-12.6 (-3.62%)

12:10
08/15/18
08/15
12:10
08/15/18
12:10
Recommendations
Tesla analyst commentary  »

Tesla moved to Not Rated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

LB

L Brands

$31.63

-1.1 (-3.36%)

12:10
08/15/18
08/15
12:10
08/15/18
12:10
Options
Bullish longer-term option play in L Brands ahead of earnings next week »

Bullish longer-term…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

AMP

Ameriprise

$137.45

-1.23 (-0.89%)

12:10
08/15/18
08/15
12:10
08/15/18
12:10
Hot Stocks
Ameriprise to pay $4.5M for not safeguarding client assets »

The Securities and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SCHN

Schnitzer Steel

$25.95

-2.3 (-8.14%)

12:09
08/15/18
08/15
12:09
08/15/18
12:09
Conference/Events
Schnitzer Steel management to meet with KeyBanc »

Meetings to be held on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

  • 21

    Aug

  • 22

    Aug

TSLA

Tesla

$334.50

-13.1 (-3.77%)

, GS

Goldman Sachs

$229.91

0.38 (0.17%)

12:08
08/15/18
08/15
12:08
08/15/18
12:08
Periodicals
Breaking Periodicals news story on Tesla, Goldman Sachs »

Goldman Sachs to act as…

TSLA

Tesla

$334.50

-13.1 (-3.77%)

GS

Goldman Sachs

$229.91

0.38 (0.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

CRC

California Resources

$28.77

-3.32 (-10.35%)

12:05
08/15/18
08/15
12:05
08/15/18
12:05
Options
California Resources call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

TSLA

Tesla

$334.80

-12.8 (-3.68%)

12:04
08/15/18
08/15
12:04
08/15/18
12:04
Periodicals
Silver Lake would like to participate in Tesla deal, DealBook says »

Silver Lake, which…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

ATVI

Activision Blizzard

$68.98

-2.31 (-3.24%)

, SNE

Sony

$53.46

-0.83 (-1.53%)

12:02
08/15/18
08/15
12:02
08/15/18
12:02
Hot Stocks
Activision's Call of Duty World League Championship comes to Ohio this week »

Activision Blizzard…

ATVI

Activision Blizzard

$68.98

-2.31 (-3.24%)

SNE

Sony

$53.46

-0.83 (-1.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 12

    Sep

  • 13

    Sep

PFGC

Performance Food Group

$33.30

-4.3 (-11.44%)

12:00
08/15/18
08/15
12:00
08/15/18
12:00
Hot Stocks
Performance Food Group falls -11.4% »

Performance Food Group is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Aug

CANG

Cango

$8.90

-1.6 (-15.24%)

12:00
08/15/18
08/15
12:00
08/15/18
12:00
Hot Stocks
Cango falls -12.0% »

Cango is down -12.0%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

M

Macy's

$36.24

-5.63 (-13.45%)

12:00
08/15/18
08/15
12:00
08/15/18
12:00
Hot Stocks
Macy's falls -13.4% »

Macy's is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Aug

  • 17

    Sep

UVXY

ProShares Trust Ultra VIX Short Term Futures ETF

$10.22

1.31 (14.70%)

12:00
08/15/18
08/15
12:00
08/15/18
12:00
Hot Stocks
ProShares Trust Ultra VIX Short Term Futures ETF rises 14.6% »

ProShares Trust Ultra VIX…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KMG

KMG Chemicals

$77.39

10.61 (15.89%)

12:00
08/15/18
08/15
12:00
08/15/18
12:00
Hot Stocks
KMG Chemicals rises 15.7% »

KMG Chemicals is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CGC

Canopy Growth

$30.29

5.67 (23.03%)

12:00
08/15/18
08/15
12:00
08/15/18
12:00
Hot Stocks
Canopy Growth rises 22.9% »

Canopy Growth is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Aug

12:00
08/15/18
08/15
12:00
08/15/18
12:00
General news
Short-covering on the S&P 500 ahead of 2.8k »

Short-covering on the…

M

Macy's

$36.27

-5.6 (-13.37%)

, STZ

Constellation Brands, also tag STZ.B

$202.15

-19.62 (-8.85%)

11:57
08/15/18
08/15
11:57
08/15/18
11:57
General news
Fly Intel: Wall Street's top stories at midday »

Stocks opened deep in…

M

Macy's

$36.27

-5.6 (-13.37%)

STZ

Constellation Brands, also tag STZ.B

$202.15

-19.62 (-8.85%)

CGC

Canopy Growth

$30.21

5.59 (22.71%)

KMG

KMG Chemicals

$77.30

10.52 (15.75%)

CCMP

Cabot Microelectronics

$111.65

-9.67 (-7.97%)

PETQ

PetIQ

$34.99

6.73 (23.81%)

FANG

Diamondback Energy

$120.33

-13.42 (-10.03%)

EGN

Energen

$76.24

3.09 (4.22%)

CASA

Casa Systems

$12.20

-3.425 (-21.93%)

STZ.B

Constellation Brands

$212.44

-8.54 (-3.86%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Aug

  • 15

    Aug

  • 15

    Aug

  • 21

    Aug

  • 22

    Aug

  • 11

    Sep

  • 17

    Sep

  • 25

    Oct

  • 28

    Oct

APC

Anadarko

$64.41

-2.56 (-3.82%)

11:55
08/15/18
08/15
11:55
08/15/18
11:55
Options
Anadarko put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRVS

Corvus Pharmaceuticals

$9.47

0.44 (4.87%)

11:55
08/15/18
08/15
11:55
08/15/18
11:55
Upgrade
Corvus Pharmaceuticals rating change  »

Corvus Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BXS

BancorpSouth

$34.20

-0.2 (-0.58%)

11:45
08/15/18
08/15
11:45
08/15/18
11:45
Conference/Events
BancorpSouth management to meet with Stephens »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 23

    Aug

BXS

BancorpSouth

$34.20

-0.2 (-0.58%)

11:45
08/15/18
08/15
11:45
08/15/18
11:45
Conference/Events
BancorpSouth management to meet with Stephens »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 23

    Aug

ALRM

Alarm.com

$50.63

0.02 (0.04%)

11:43
08/15/18
08/15
11:43
08/15/18
11:43
Conference/Events
Alarm.com management to meet with Maxim »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

  • 22

    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.